Beatrice Knudsen, MD, PhD
Biomarkers of Response to Treatment with XL184 in the Bone XL184 (caboxantanib) is a new experimental medication for metastatic prostate cancer with promising clinical results. To more effectively administer XL184...Read More
Karen Knudsen, PhD
Education PhD, Biological Sciences, University of California, San Diego BS, Biology, The George Washington University Expertise & Research Interests Prostate cancer is the most commonly diagnosed malignancy in the Unites...Read More
Peter Kuhn, PhD
Dr. Kuhn is a scientist, educator and entrepreneur with a career long commitment in personalized medicine and individualized patient care. He is focused on the redesign of cancer care. The...Read More
Max Loda, MD
Dr. Massimo Loda, an internationally renowned molecular pathologist, has been appointed chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and pathologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical...Read More
Michael Morris, MD
I am a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those who have metastatic disease (disease that has spread to distant organs) or who are...Read More
Lorelei Mucci, ScD, MPH
Dr. Mucci's area of research and teaching is cancer epidemiology. She is the Director of the Cancer Epidemiology and Cancer Prevention Program (Area of Interest) within the Department of Epidemiology...Read More
Peter Nelson, MD
Targeting Therapy-Induced Resistance Mechanisms in the Prostate Tumor Microenvironment Dr. Nelson postulates that chemotherapy resistance originates in the tumor microenvironment in response to stress caused by chemotherapy. He has discovered...Read More
Challenge Awards-Class of 2012
PCF selected the 9 2012 Challenge Awards out of 96 proposals from highly-qualified research teams at 70 prestigious cancer centers spanning 10 countries across the globe. Following an extensive peer...Read More
Challenge Awards-Class of 2011
PCF vetted the 10 2011 Challenge Awards from a field of 59 research proposals from highly-qualified research teams at prestigious cancer centers around the globe. Following an extensive peer review,...Read More